RIPK1 and Cognitive impairment: Another study showed that neuron-specific deficiency of RIPK1 or RIPK3 significantly enhances cognitive performance of TBI mice, indicating that RIPK1 or RIPK3 serve as viable therapeutic targets for post-TBI cognitive impairment [57].